Biotech entity
All 1 tracked stories fall under one category: pharma. Dr. Ben Rome is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Generic drug manufacturers (industry group) appears in 1 tracked Biotech story from July 19, 2026.
Last mentioned: Jul 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Dr. Ben Rome is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Generic drug manufacturers (industry group) appears in 1 tracked Biotech story from July 19, 2026. The tracked stories average 7 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Generic drug manufacturers (industry group). Shared-story counts are live from our verified record — not editorial picks.
Biopharma companies cooperated just enough to avoid tariffs, placing only 92 products on TrumpRx while keeping high-margin cancer, HIV, and inflammation therapies off the discount menu—revealing industry’s strategic calculus.
Generic drug manufacturers (industry group) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
